Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS

被引：9
|
作者：
Komatsu, Teppei [1 ]
Matsushima, Satoshi [2 ]
Kaneko, Kimihiko [3 ]
Fukuda, Takahiro [4 ]
机构：
[1] Jikei Univ, Sch Med, Dept Neurol, Tokyo, Japan
[2] Jikei Univ, Sch Med, Dept Radiol, Tokyo, Japan
[3] Natl Hosp Org Miyagi Hosp, Dept Neurol, Sendai, Miyagi, Japan
[4] Jikei Univ, Sch Med, Dept Pathol, Div Neuropathol, Tokyo, Japan
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2019年 / 90卷 / 01期
关键词：
BRAIN;
D O I：
10.1136/jnnp-2018-319235
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：111 / 112
页数：2
相关论文
共 50 条
  • [41] Clinical utility of anti-MOG antibody testing in a Danish cohort
    Papp, Viktoria
    Langkilde, Annika R.
    Blinkenberg, Morten
    Schreiber, Karen
    Jensen, Poul Erik Hyldgaard
    Sellebjerg, Finn
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 26 : 61 - 67
  • [42] Anti-MOG Antibody in a Pediatric Patient with Autism Spectrum Disorder
    Costa Anzola, Antonio
    Aguado Alvarez, Rocio
    Trujillo, Antonio
    Cantisan, Sara
    Molina Alcaide, Juan Eduardo
    Jurado Roger, Aurora
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1382 - 1382
  • [43] Intrathecal Anti-MOG Antibody Production Is Elevated in Multiple Sclerosis
    Klawiter, Eric C.
    Piccio, Laura
    Lyons, Jeri-Anne
    O'Connor, Kevin C.
    Cross, Anne H.
    NEUROLOGY, 2010, 74 (09) : A427 - A427
  • [44] T cell response to myelin oligodendrocyte glycoprotein (MOG) in patients with anti-MOG antibody
    Ono, H.
    Misu, T.
    Takai, Y.
    Nishiyama, S.
    Kuroda, H.
    Takahashi, T.
    Nakashima, I.
    Fujihara, K.
    Aoki, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 662 - 662
  • [45] Elucidating the mechanism of anti-MOG antibody-mediated demyelination
    Marta, CB
    Ruddle, NH
    Oliver, A
    Bansal, R
    Pfeiffer, SE
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 127 - 127
  • [46] Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system
    Tanaka, Masami
    Tanaka, Keiko
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 270 (1-2) : 98 - 99
  • [47] Metabolomics aid Clinico-Pathophysiological Classification of CNS Inflammatory Demyelinating Diseases without Anti-AQP4 and Anti-MOG Antibodies
    Yeo, Tianrong
    Probert, Fay
    Jurynczyk, Maciej
    Sealey, Megan
    Cavey, Ana
    Claridge, Timothy D. W.
    Waters, Patrick
    Leite, Maria Isabel
    Anthony, Daniel C.
    Palace, Jacqueline
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 26 - 27
  • [48] Psychosocial Functioning in Pediatric Anti-MOG Associated Disease
    Kennedy, Erin E.
    Hernandez, Ana
    Greenberg, Benjamin
    Plumb, Patricia
    Wang, Cynthia
    Harder, Lana
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2021, 36 (06) : 1125 - 1125
  • [49] MOG-antibody-positive CNS demyelinating disease: a clinical study in Chinese Han patients
    Zhangbao, J.
    Zhou, L.
    Huang, Y.
    Li, H.
    Li, Y.
    Zhao, C.
    Lu, J.
    Wang, M.
    Quan, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 438 - 438
  • [50] Systemic and ocular manifestations of Anti-MOG disease in Canada
    Lalonde, Melanie
    O'Neil, Alexis
    Nguyen, Hong-An
    Rush, Carolina
    Coupland, Stuart
    Karanjia, Rustum
    ACTA OPHTHALMOLOGICA, 2022, 100
12345